ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.035 AUD Market Closed
Market Cap: 71.3m AUD

Intrinsic Value

The intrinsic value of one IPD stock under the Base Case scenario is 0.085 AUD. Compared to the current market price of 0.035 AUD, ImpediMed Ltd is Undervalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IPD Intrinsic Value
0.085 AUD
Undervaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ImpediMed Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about IPD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IPD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ImpediMed Ltd.

Explain Valuation
Compare IPD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IPD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ImpediMed Ltd

Current Assets 27.5m
Cash & Short-Term Investments 22.2m
Receivables 3.7m
Other Current Assets 1.7m
Non-Current Assets 14.2m
Long-Term Investments 73k
PP&E 883k
Intangibles 13m
Other Non-Current Assets 227k
Current Liabilities 5.7m
Accounts Payable 1.6m
Accrued Liabilities 1.5m
Other Current Liabilities 2.6m
Non-Current Liabilities 15.5m
Long-Term Debt 14.2m
Other Non-Current Liabilities 1.3m
Efficiency

Free Cash Flow Analysis
ImpediMed Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ImpediMed Ltd

Revenue
12.7m AUD
Cost of Revenue
-1.7m AUD
Gross Profit
11m AUD
Operating Expenses
-34m AUD
Operating Income
-23m AUD
Other Expenses
-230k AUD
Net Income
-23.2m AUD
Fundamental Scores

IPD Profitability Score
Profitability Due Diligence

ImpediMed Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
24/100
Profitability
Score

ImpediMed Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

IPD Solvency Score
Solvency Due Diligence

ImpediMed Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Negative Net Debt
53/100
Solvency
Score

ImpediMed Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IPD Price Targets Summary
ImpediMed Ltd

Wall Street analysts forecast IPD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPD is 0.109 AUD with a low forecast of 0.071 AUD and a high forecast of 0.137 AUD.

Lowest
Price Target
0.071 AUD
102% Upside
Average
Price Target
0.109 AUD
211% Upside
Highest
Price Target
0.137 AUD
290% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ImpediMed Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for IPD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one IPD stock?

The intrinsic value of one IPD stock under the Base Case scenario is 0.085 AUD.

Is IPD stock undervalued or overvalued?

Compared to the current market price of 0.035 AUD, ImpediMed Ltd is Undervalued by 59%.

Back to Top